Anadolu Medical Center
The total cost of astrocytoma treatment in Turkey varies depending on the treatment plan. Initial diagnostics, including a consultation, laboratory tests, and MRI with contrast, are approximately $1,850. Surgical removal of the tumor ranges from $18,000 to $28,000, while postoperative radiotherapy with temozolomide is around $7,000. The treatment program is personalized, following an individual assessment by the medical team.
| Turcja | Austria | Hiszpania | |
| Stereotaktyczna radiochirurgia | od $4,500 | od $17,000 | od $12,000 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
| Kraniotomia | od $5,650 | od $20,000 | od $25,000 |
| Chemioterapia w raku piersi | od $1,200 | od $15,000 | od $3,500 |
| Halcyon | od $5,400 | - | - |
Specjalizuje się w biologii nowotworów i immunoterapii — dr Bülent Karagöz koncentruje się na zaawansowanych metodach leczenia onkologicznego w Centrum Medycznym Anadolu.
Dr Tanrikulu pełnił funkcję ordynatora oddziału onkologii klinicznej w szpitalu Haydarpaşa Numune i jest aktywnym badaczem w międzynarodowych badaniach klinicznych.
Dr Solak specjalizuje się w leczeniu gwiaździaka. Posiada bogate doświadczenie zdobyte w Instytucie Onkologii Uniwersytetu Hacettepe oraz MD Anderson Cancer Center.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.